Overview

Metformin in Patients With Ulcerative Colitis Treated With Mesalamine

Status:
Not yet recruiting
Trial end date:
2025-12-20
Target enrollment:
Participant gender:
Summary
Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease characterized by diffused inflammation of the colon and rectum mucosa, however, the exact underlying mechanisms of UC remain poorly understood.UC is strongly dependent on cellular immune reaction and exaggerated inflammatory response due to genetic, immune and environmental factors.
Phase:
Phase 2
Details
Lead Sponsor:
Tanta University
Treatments:
Metformin